SEC Form 4 · accession 0001104659-15-040430
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald J Hayden Jr.
Director
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | M | 20,000 | $3.45 | A | 20,000 | D | |
| Common Stock | May 20, 2015 | S | 20,000 | $12.01 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.45 | May 20, 2015 | M | 20,000 | D | — | Mar 28, 2016 | Common Stock | 20,000 | 14,195 | D |
Explanation of responses
- F1The option vested over four years of service following March 29, 2006, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.